Literature DB >> 12105904

Studying enzyme binding specificity in acetylcholinesterase using a combined molecular dynamics and multiple docking approach.

Jeremy Kua1, Yingkai Zhang, J Andrew McCammon.   

Abstract

A combined molecular dynamics simulation and multiple ligand docking approach is applied to study the binding specificity of acetylcholinesterase (AChE) with its natural substrate acetylcholine (ACh), a family of substrate analogues, and choline. Calculated docking energies are well correlated to experimental k(cat)/K(M) values, as well as to experimental binding affinities of a related series of TMTFA inhibitors. The "esteratic" and "anionic" subsites are found to act together to achieve substrate binding specificity. We find that the presence of ACh in the active site of AChE not only stabilizes the setup of the catalytic triad but also tightens both subsites to achieve better binding. The docking energy gained from this induced fit is 0.7 kcal/mol for ACh. For the binding of the substrate tailgroup to the anionic subsite, both the size and the positive charge of the tailgroup are important. The removal of the positive charge leads to a weaker binding of 1 kcal/mol loss in docking energy. Substituting each tail methyl group with hydrogen results in both an incremental loss in docking energy and also a decrease in the percentage of structures docked in the active site correctly set up for catalysis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12105904     DOI: 10.1021/ja020429l

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  32 in total

1.  Identifying the binding mode of a molecular scaffold.

Authors:  Doron Chema; Doron Eren; Avner Yayon; Amiram Goldblum; Andrea Zaliani
Journal:  J Comput Aided Mol Des       Date:  2004-01       Impact factor: 3.686

2.  Molecular simulation methods in drug discovery: a prospective outlook.

Authors:  Xavier Barril; F Javier Luque
Journal:  J Comput Aided Mol Des       Date:  2011-12-08       Impact factor: 3.686

3.  Characterization of a complete cycle of acetylcholinesterase catalysis by ab initio QM/MM modeling.

Authors:  Alexander V Nemukhin; Sofia V Lushchekina; Anastasia V Bochenkova; Anna A Golubeva; Sergei D Varfolomeev
Journal:  J Mol Model       Date:  2008-03-15       Impact factor: 1.810

4.  Exploiting conformational dynamics in drug discovery: design of C-terminal inhibitors of Hsp90 with improved activities.

Authors:  Elisabetta Moroni; Huiping Zhao; Brian S J Blagg; Giorgio Colombo
Journal:  J Chem Inf Model       Date:  2014-01-15       Impact factor: 4.956

5.  Molecular docking study on the "back door" hypothesis for product clearance in acetylcholinesterase.

Authors:  Laleh Alisaraie; Gregor Fels
Journal:  J Mol Model       Date:  2005-12-09       Impact factor: 1.810

Review 6.  Efficient incorporation of protein flexibility and dynamics into molecular docking simulations.

Authors:  Markus A Lill
Journal:  Biochemistry       Date:  2011-06-22       Impact factor: 3.162

7.  Curariform antagonists bind in different orientations to acetylcholine-binding protein.

Authors:  Fan Gao; Nina Bern; Alicia Little; Hai-Long Wang; Scott B Hansen; Todd T Talley; Palmer Taylor; Steven M Sine
Journal:  J Biol Chem       Date:  2003-04-07       Impact factor: 5.157

8.  In Silico Design and Evaluation of Carboxylesterase Inhibitors.

Authors:  Shana V Stoddard; Xiaozhen Yu; Philip M Potter; Randy M Wadkins
Journal:  J Pest Sci (2004)       Date:  2010       Impact factor: 5.918

9.  In pursuit of virtual lead optimization: pruning ensembles of receptor structures for increased efficiency and accuracy during docking.

Authors:  Erin S D Bolstad; Amy C Anderson
Journal:  Proteins       Date:  2009-04

10.  High-performance drug discovery: computational screening by combining docking and molecular dynamics simulations.

Authors:  Noriaki Okimoto; Noriyuki Futatsugi; Hideyoshi Fuji; Atsushi Suenaga; Gentaro Morimoto; Ryoko Yanai; Yousuke Ohno; Tetsu Narumi; Makoto Taiji
Journal:  PLoS Comput Biol       Date:  2009-10-09       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.